Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Guided Therapeutics (GTHP) Accumulated Depreciation & Amortization (2019 - 2020)

Guided Therapeutics' Accumulated Depreciation & Amortization history spans 2 years, with the latest figure at $1.7 million for Q4 2020.

  • For Q4 2020, Accumulated Depreciation & Amortization fell 27.04% year-over-year to $1.7 million; the TTM value through Dec 2020 reached $1.7 million, down 27.04%, while the annual FY2020 figure was $1.7 million, 27.04% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2020 was $1.7 million at Guided Therapeutics, down from $2.4 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $2.4 million in Q4 2019 and bottomed at $1.7 million in Q4 2020.